Understanding these differences helps you make informed decisions about which approach best fits your research goals
Most protocols recommend evening injections , typically 1-2 hours before intended sleep time
A., Gastaldelli, A
One of the components of Soliqua, lixisenatide may pose a risk to the fetus in pregnant women
Patients should contact their GP or prescribing clinician if they experience any of the following: Severe or worsening fatigue that: Persists despite implementing lifestyle modifications Progressively worsens rather than improving over time Significantly impairs daily functioning, work performance, or quality of life Is accompanied by weakness, dizziness, or fainting episodes Associated symptoms suggesting potential complications: Severe, persistent abdominal pain, possibly radiating to the back, with or without vomiting (potential signs of pancreatitis requiring urgent medical attention) Pain in the right upper abdomen, fever, or jaundice (potential signs of gallbladder disease) Persistent nausea, vomiting, or diarrhoea leading to dehydration Signs of dehydration: dark urine, dry mouth, reduced urine output, confusion Rapid or irregular heartbeat, chest pain, or shortness of breath Unexplained weight loss exceeding recommended targets (faster than about 0.5-1 kg per week) Mood changes, depression, or anxiety Yellowing of skin or eyes, dark urine, or pale stools (potential liver concerns) For patients with diabetes, particularly those taking insulin or sulfonylureas, symptoms of hypoglycaemia (sweating, shakiness, confusion, irritability) alongside fatigue require prompt attention and potential medication adjustment
